GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Rock Creek Pharmaceuticals Inc. (RCPI) [hlAlert]

Rating:
Buy RCPI
up 20.46 %

Rock Creek Pharmaceuticals Inc. (RCPI) rated Buy with price target $4 by Maxim Group

Posted on: Tuesday,  Oct 20, 2015  8:25 AM ET by Maxim Group

Maxim Group rated Buy Rock Creek Pharmaceuticals Inc. (NASDAQ: RCPI) on 10/20/2015, when the stock price was $0.86.
Since then, Rock Creek Pharmaceuticals Inc. has gained 20.47% as of 11/04/2015's recent price of $1.03.
If you would have followed this Maxim Group's recommendation on RCPI, you would have gained 20.46% of your investment in 15 days.

Star Scientific, Inc. (Star Scientific) is engaged in the development of very low-tobacco-specific nitrosamines (TSNA), non-fermented smokeless tobacco products. The Company is also engaged in the development, implementation and licensing of its technology for the curing of tobacco so as to prevent the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the TSNAs and manufactures, sells, markets and/or develop very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco cigalett pieces and STONEWALL Hard Snuff and modified risk tobacco products. It is also engaged in the development of pharmaceutical products, particularly products that have a botanical, tobacco-based component, that are designed to treat tobacco dependence and a range of neurological conditions, including Alzheimer?s disease, Parkinson?s disease, schizophrenia and depression, and is also in the development of non-nicotine nutraceutical products.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/20/2015 8:25 AM Buy
None
0.86 4.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy